Q3 2013 Holdings
Filed 2013-11-14 | 82 holdings | $722.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $548.2M | 19,955,126 | 75.9% |
| Cerus(CERS) | COM | 157085101 | $56.8M | 8,455,306 | 7.9% |
| Biomarin Pharmaceuticals(BMRN) | COM | 09061G101 | $56.5M | 783,311 | 7.8% |
| Biocryst Pharmaceuticals Inc.(BCRX) | COM | 09058V103 | $48.8M | 6,699,979 | 6.8% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $5.6M | 200,000 | 0.8% |
| Pharmacyclics Inc. | COM | 716933106 | $1.2M | 9,010,211 | 0.2% |
| Seattle Genetics Inc. | COM | 812578102 | $846.9K | 19,322,947 | 0.1% |
| Incyte Genomics Notes 4.75% 10/1/2015 | CONV BONDS | 45337CAH5 | $688.1K | $157,758,000 | 0.1% |
| Synageva Biopharma Corp. | COM | 87159A103 | $651.2K | 10,273,182 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $565.0K | 14,810,559 | 0.1% |
| Genomic Health Inc.(GHDX) | COM | 37244C101 | $417.4K | 13,650,835 | 0.1% |
| Salix 2.75% 5/15/15 | CONV BONDS | 795435AC0 | $335.3K | $219,440,000 | 0.0% |
| Viropharma Inc. | COM | 928241108 | $219.6K | 5,592,239 | 0.0% |
| Xoma Corp. | COM | 98419J107 | $103.4K | 23,032,372 | 0.0% |
| Auxilium 1.5% 7/15/2018 | CONV BONDS | 05334DAA5 | $90.2K | $87,090,000 | 0.0% |
| Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | CONV BONDS | 09061GAD3 | $82.0K | $22,898,000 | 0.0% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $78.3K | 1,245,800 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $77.5K | 7,017,608 | 0.0% |
| Repros Therapeutics | COM | 76028H209 | $74.5K | 2,778,654 | 0.0% |
| Aegerion Pharmaceuticals | COM | 00767E102 | $70.3K | 820,275 | 0.0% |
| Gilead 1.625% 5/1/16 | CONV BONDS | 375558AP8 | $59.5K | $21,500,000 | 0.0% |
| Intermune Inc Notes 2.5% 12/15/17 | CONV BONDS | 45884XAF0 | $58.4K | $41,000,000 | 0.0% |
| Medivation 2.625% 4/1/17 | CONV BONDS | 58501NAA9 | $55.6K | $39,500,000 | 0.0% |
| Vanda Pharmaceuticals, Inc.(VNDA) | COM | 921659108 | $52.5K | 4,791,179 | 0.0% |
| Stemline Therapeutics Inc. | COM | 85858C107 | $36.3K | 800,400 | 0.0% |
| Derma Sciences | COM | 249827502 | $31.7K | 2,558,857 | 0.0% |
| Questcor Pharmaceuticals, Inc. | COM | 74835Y101 | $31.7K | 545,846 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $30.0K | 1,980,074 | 0.0% |
| Intercept Pharmaceuticals, Inc.(ICPTUSD) | COM | 45845P108 | $25.0K | 362,847 | 0.0% |
| Ariad Pharmaceuticals Inc. | COM | 04033A100 | $24.5K | 1,333,703 | 0.0% |
| Medivation Inc. | COM | 58501N101 | $23.9K | 398,331 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $21.1K | 4,200,000 | 0.0% |
| Intermune Inc Notes 5% 3/1/15 | CONV BONDS | 45884XAD5 | $20.0K | $16,860,000 | 0.0% |
| Avanir Pharmaceuticals | COM | 05348P401 | $18.7K | 4,428,591 | 0.0% |
| Clovis Oncology(CLVSEUR) | COM | 189464100 | $18.3K | 301,744 | 0.0% |
| Arrowhead Research Corp. | COM | 042797209 | $17.9K | 3,140,000 | 0.0% |
| Chelsea Therapeutics | COM | 163428105 | $17.3K | 5,794,753 | 0.0% |
| Insmed Inc.(INSM) | COM | 457669307 | $14.8K | 945,803 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $12.1K | 265,000 | 0.0% |
| Synergy Pharmaceuticals | COM | 871639308 | $11.9K | 2,608,271 | 0.0% |
| Ambit Biosciences Corp. | COM | 02318X100 | $11.6K | 747,962 | 0.0% |
| Targacept | COM | 87611R306 | $11.0K | 2,068,186 | 0.0% |
| Infinity Pharmaceuticals Inc.(INFIQ) | COM | 45665G303 | $10.2K | 586,936 | 0.0% |
| Idera Pharmaceuticals Inc. | COM | 45168K306 | $10.2K | 5,865,000 | 0.0% |
| Array Biopharma Inc.(ARRYEUR) | COM | 04269X105 | $9.3K | 1,500,000 | 0.0% |
| Anacor Pharmaceuticals | COM | 32420101 | $9.3K | 876,463 | 0.0% |
| Isis Pharmaceuticals | COM | 464330109 | $9.3K | 247,036 | 0.0% |
| Threshold Pharma | COM | 885807206 | $8.6K | 1,852,399 | 0.0% |
| Portola Pharmaceuticals, Inc. | COM | 737010108 | $8.0K | 299,911 | 0.0% |
| Prothena Corp. PLC(PRTA) | COM | G72800108 | $7.5K | 369,650 | 0.0% |